Skip to main content

Table 5 The relationship between macrophage inflammatory protein (MIP)-1α or MIP-1β and other cytokines

From: Decreased macrophage inflammatory protein (MIP)-1α and MIP-1β increase the risk of developing nasopharyngeal carcinoma

Marker

MIP-1α

MIP-1β

Case–control study

Nested case–control study

Case–control study

Nested case–control study

ρ

P

ρ

P

ρ

P

ρ

P

EGF

0.29

0.070

0.07

0.447

0.25

0.003

0.02

0.798

Eotaxin

0.29

< 0.001

0.25

0.007

0.24

0.003

0.22

0.018

GCSF

0.39

< 0.001

0.06

0.544

0.39

< 0.001

− 0.06

0.544

Fractalkine

0.24

0.004

0.05

0.636

0.37

< 0.001

0.15

0.134

IFN-γ

0.38

0.008

0.09

0.316

0.22

0.008

0.11

0.243

GRO

0.21

0.012

0.06

0.523

0.26

0.002

0.06

0.523

MDC

0.33

< 0.001

0.01

0.922

0.26

0.002

0.03

0.778

IL-1α

0.16

0.07

− 0.01

0.888

0.19

0.03

− 0.08

0.394

IL-7

0.27

0.001

0.08

0.411

0.30

< 0.001

− 0.015

0.875

IL-8

0.47

< 0.001

0.63

< 0.001

0.30

< 0.001

0.49

< 0.001

MCP-1

0.20

0.014

0.19

0.035

0.09

0.280

0.18

0.048

VEGF

0.20

0.017

0.09

0.348

0.37

< 0.001

0.13

0.165

  1. ρ Spearman’s correlation coefficient, MIP-1α macrophage inflammatory protein-1 alpha, MIP-1β macrophage inflammatory protein-1 beta, EGF epidermal growth factor, GCSF granulocyte colony-stimulating factor, IFN-γ interferon gamma, GRO growth-regulated oncogene, MDC macrophage-derived chemokine, IL-1α interleukin-1 alpha, IL-7 interleukin-7, IL-8 interleukin-8, MCP-1 monocyte chemotactic protein-1, VEGF vascular endothelial growth factor
Back to article page

Cancer Communications

ISSN: 2523-3548

Contact us